Imipenem-cilastatin as initial therapy for febrile cancer patients (Q35651131)

9 August 2017

title

Imipenem-cilastatin as initial therapy for febrile cancer patients (English)

1 reference

9 August 2017

author

Kenneth V. I. Rolston

4

object named as

Rolston KV

1 reference

9 August 2017

Bodey GP

1

1 reference

9 August 2017

Alvarez ME

2

1 reference

9 August 2017

Jones PG

3

1 reference

9 August 2017

Steelhammer L

5

1 reference

9 August 2017

Fainstein V

6

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 August 1986

1 reference

Antimicrobial Agents and Chemotherapy

9 August 2017

published in

1 reference

9 August 2017

volume

30

1 reference

9 August 2017

issue

2

1 reference

9 August 2017

page(s)

211-214

1 reference

Use of trimethoprim-sulfamethoxazole for treatment of infections in patients with cancer

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180520

Single-drug versus combination empirical therapy for gram-negative bacillary infections in febrile cancer patients with and without granulocytopenia

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180520

In vitro activity of WIN 49375 compared with those of other antibiotics in isolates from cancer patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180520

Antibiotics in patients with neutropenia

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180520

Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180520

Moxalactam plus ticarcillin or tobramycin for treatment of febrile episodes in neutropenic cancer patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180520

A randomized study of tobramycin plus ticarcillin, tobramycin plus cephalothin and ticarcillin, or tobramycin plus mezlocillin in the treatment of infection in neutropenic patients with malignancies

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180520

Prospective randomized trial of piperacillin monotherapy versus carboxypenicillin-aminoglycoside combination regimens in the empirical treatment of serious bacterial infections

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180520

A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180520

In vitro effectiveness of kanamycin and kanamycin/cephalothin against Klebsiella. Comparison with other antibiotics.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180520

Imipenem: first of a new class of beta-lactam antibiotics

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180520

In vitro activity of thienamycin

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180520

A randomized study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180520

Clinical and Bacteriological Responses to Three Antibiotic Regimens for Acute Exacerbations of Cystic Fibrosis: Tlcarcillln-Tobramycin, Azlocillin-Tobramycin, and Azlocillin-Placebo

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180520

Antibiotic combinations for infections in neutropenic patients. Evaluaton of carbenicillin plus either cephalothin or kanamycin

25 September 2018

1 reference

12 December 2020

Therapy with carbenicillin and gentamicin for patients with cancer and severe infections caused by gram-negative rods

1 reference

12 December 2020

Gram-negative infections in cancer. Study of empiric therapy comparing carbenicillin-cephalothin with and without gentamicin

1 reference

12 December 2020

Therapy of neutropenic rats infected with Pseudomonas aeruginosa

1 reference

12 December 2020

Carbenicillin-trimethoprim/sulfamethoxazole versus carbenicillin-gentamicin as empiric therapy of infection in granulocytopenic patients. A prospective, randomized, double-blind study

1 reference

12 December 2020

A multiclinic randomized study of the comparative efficacy, safety and tolerance of imipenem/cilastatin and moxalactam

1 reference

12 December 2020

Carbenicillin Therapy of Gram-Negative Bacilli Infections

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.30.2.211

1 reference

9 August 2017

1 reference

9 August 2017

1 reference